Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment

OBJECTIVES: Elevated low-density lipoprotein cholesterol (LDL-C) increases the risk of recurrent cardiovascular disease (CVD) events. We examined use of lipid-lowering therapy (LLT) following ischaemic stroke, and estimated benefits from guideline-based up-titration of LLT. METHODS: The Norwegian CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Gynnild, Mari Nordbø, Hageman, Steven H J, Spigset, Olav, Lydersen, Stian, Saltvedt, Ingvild, Dorresteijn, Jannick A N, Visseren, Frank L J, Ellekjær, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Cardiac Risk Factors and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036470/
https://www.ncbi.nlm.nih.gov/pubmed/35459718
http://dx.doi.org/10.1136/openhrt-2022-001972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036470/
https://www.ncbi.nlm.nih.gov/pubmed/35459718
http://dx.doi.org/10.1136/openhrt-2022-001972

Ejemplares similares